Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00799201 · ClinicalTrials.gov registry record · Phase 4
Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients
A Phase 4 study, sponsored by CAMC Health System.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT00799201: Clinical Trial Phase 4 study, sponsored by CAMC Health System.
NCT00799201 is a Phase 4 study that was terminated before completion, run by CAMC Health System. The registered enrollment target is 3 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00799201, a Phase 4 study, was terminated before completion, sponsored by CAMC Health System.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if enteral naloxone is more effective than a traditional bowel regimen in the prevention and treatment of constipation and impaired gastric motility in critically ill trauma patients.
Interventions
- DRUG Naloxone and Docusate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-10 |
| Phase | Phase 4 |
Why NCT00799201 stopped before completion
NCT00799201 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Naloxone and Docusate is the first listed.
NCT00799201 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00799201 about?
NCT00799201 is a clinical study titled "Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients". The purpose of this study is to determine if enteral naloxone is more effective than a traditional bowel regimen in the prevention and treatment of constipation and impaired gastric motility in critically ill trauma patients.
What is the current status of trial NCT00799201?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2007-08. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00799201?
The interventions under investigation include: Naloxone and Docusate (DRUG).
Who is sponsoring clinical trial NCT00799201?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00799201's enrollment target sits among peer trials
3 1995th of 2000 higher than 3 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia